Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -40.49% is 91% below its 5-year average of -21.22%, near the high end of its 5-year range (-924.54%–69.93%).
122.05% below its 12-month average of -18.23%.
Reported quarterly profit margin; no daily interpolation. Q4 FY2025 (2025-12-31): -40.65%.
NET PROFIT MARGIN
-40.49%
NET PROFIT MARGIN AVG TTM
-18.23%
NET PROFIT MARGIN AVG 3Y
-267.92%
NET PROFIT MARGIN AVG 5Y
-21.22%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-122.05%
CURRENT VS 3Y AVG
+84.89%
CURRENT VS 5Y AVG
-90.81%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-15473.08%
vs the sector median at left
EUDA Health Holdings Limited
Market Cap
$36.21M
Net Profit Margin
-40.49%
TTM Avg
-18.23%
3Y Avg
-267.92%
5Y Avg
-21.22%
Market Cap
$35.84M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-479.12%
Market Cap
$35.84M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-322.60%
Market Cap
$35.76M
Net Profit Margin
-65.29%
TTM Avg
-26.68%
3Y Avg
-11.11%
5Y Avg
-8.71%
Market Cap
$35.52M
Net Profit Margin
-65.31%
TTM Avg
-147.78%
3Y Avg
-3852.20%
5Y Avg
-3378.36%
Market Cap
$34.97M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$37.93M
Net Profit Margin
0.00%
TTM Avg
-27258.72%
3Y Avg
-52085.61%
5Y Avg
-35139.97%
Market Cap
$34.35M
Net Profit Margin
426.93%
TTM Avg
106.45%
3Y Avg
-19.31%
5Y Avg
-30.13%
Market Cap
$38.61M
Net Profit Margin
-11.86%
TTM Avg
-39.34%
3Y Avg
-22.53%
5Y Avg
-16.34%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| EUDA Health Holdings Limited (EUDA) | $36.21M | -40.49% | -18.23% | -267.92% | -21.22% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $35.84M | 0.00% | 0.00% | 0.00% | -479.12% |
| Edesa Biotech, Inc. (EDSA)vs › | $35.84M | 0.00% | 0.00% | 0.00% | -322.60% |
| DocGo Inc. (DCGO)vs › | $35.76M | -65.29% | -26.68% | -11.11% | -8.71% |
| QT Imaging Holdings, Inc. (QTI)vs › | $35.52M | -65.31% | -147.78% | -3852.20% | -3378.36% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.97M | 0.00% | 0.00% | 0.00% | 0.00% |
| Incannex Healthcare Limited (IXHL)vs › | $37.93M | 0.00% | -27258.72% | -52085.61% | -35139.97% |
| Elutia Inc (ELUT)vs › | $34.35M | 426.93% | 106.45% | -19.31% | -30.13% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.61M | -11.86% | -39.34% | -22.53% | -16.34% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $38.78M | -689.20% | -248.90% | -225.94% | -1945.52% |
Operating Margin
-36.4%
Net Profit Margin
-40.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2025-12-31 | -40.65% |
| 2025-09-30 | -41.69% |
| 2025-06-30 | -39.38% |
| 2025-03-31 | -39.38% |
| 2024-12-31 | 69.93% |
| 2024-09-30 | 69.93% |
| 2024-06-30 | -881.95% |
| 2024-03-31 | -881.94% |
| 2023-12-31 | -80.13% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | -550.97% |
| 2023-03-31 | -142.14% |
| 2022-12-31 | -924.54% |
| 2022-10-31 | 8.70% |
| 2022-06-30 | -76.62% |
| 2022-03-31 | -17.74% |
| 2021-12-31 | -8.35% |
| 2021-09-30 | -1.69% |
| 2021-06-30 | -0.02% |
| 2021-03-31 | -0.30% |
